Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs FitFlow

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: CoreAge Rx: August 2026 · FitFlow: October 2026

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade C · #46

FitFlow

Online access to compounded semaglutide and tirzepatide, with monthly billing or discounted prepaid plans.

Visit FitFlow

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 79/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. FitFlow still earns its place — patients comparing monthly compounded medication plans with the financial commitment of longer prepaid offers.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results80
97Price honesty74
96Prescriber access55
88Formulary choice90
95Cancellation fairness92
93Member support88

Price, coverage & features

MetricCoreAge RxFitFlow
Verdict Score94/10079/100
GradeAC
Semaglutide$99/moFrom $175/mo (compounded)
Tirzepatide$149/moFrom $235/mo (compounded)
CoverageAll 50 statesAll 50 states advertised; confirm eligibility
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoNo

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

FitFlow

What we like

  • Publishes month-to-month prices of $175 for semaglutide and $235 for tirzepatide
  • Current annual equivalents are $99 for semaglutide and $134 for tirzepatide, paid upfront
  • The company advertises service in all 50 states

The caveats

  • Compounded drugs are not FDA-approved branded Wegovy, Ozempic, Mounjaro or Zepbound
  • Annual advertised rates require a year prepaid: $1,188 for semaglutide or $1,608 for tirzepatide
  • Confirm the dispensing pharmacy, eligibility and applicable refund terms before paying

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Patients comparing monthly compounded medication plans with the financial commitment of longer prepaid offers.

Visit FitFlow Read the full FitFlow review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for FitFlow does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.